Intraperitoneal Local Anesthetic in Bariatric Surgery Study (iLABS Study)

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

February 27, 2018

Study Completion Date

April 27, 2018

Conditions
Overweight and ObesityBariatric Surgery Candidate
Interventions
DRUG

Ropivacaine

Patient undergo elective laparoscopic sleeve gastrectomy will receive 20mL of 150mg ropivacaine (0.75%) diluted in 180mL normal saline to be injected through a catheter along the greater curvature and left subdiaphragmatic region of the stomach at the end of the surgical procedure. After the surgery, the medical doctors or nurses in the ward that is not otherwise involved in this research will assess and record the pain score using visual analog scale (VAS) (0-10). The abdomen and shoulder tip pain intensity will be rated at two, four, six, eight, 24 and 48 hours postoperatively.

DRUG

Normal saline

Patient undergo elective laparoscopic sleeve gastrectomy will receive 200mL normal saline to be injected through a catheter along the greater curvature and left subdiaphragmatic region of the stomach at the end of the surgical procedure. After the surgery, the medical doctors or nurses in the ward that is not otherwise involved in this research will assess and record the pain score using visual analog scale (VAS) (0-10). The abdomen and shoulder tip pain intensity will be rated at two, four, six, eight, 24 and 48 hours postoperatively.

Trial Locations (2)

43400

Hospital Serdang, Kajang

50586

Hospital Kuala Lumpur, Kuala Lumpur

All Listed Sponsors
lead

Dr. Tikfu Gee

OTHER

NCT03175081 - Intraperitoneal Local Anesthetic in Bariatric Surgery Study (iLABS Study) | Biotech Hunter | Biotech Hunter